How to Evaluate Patients for Tardive Dyskinesia.

Abstract

​​​​​​​​ Tardive dyskinesia (TD) is a serious and potentially irreversible movement disorder that occurs in 20%-50% of patients taking antipsychotic drugs. TD is also associated with several other classes of medications, including antidepressants, antihistamines, decongestants, mood stabilizers, and stimulants. As more people are prescribed medications that can increase the risk for TD, it is important that clinicians learn how to systematically and reasonably evaluate their patients for this potentially dangerous and debilitating condition.